Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: Influence of gender

Heart

Volumn 100, Issue 3, 2014, Pages 206-213

  Kwon, Deborah H ^a   Hachamovitch, Rory ^a   Adeniyi, Aderonke ^a   Nutter, Benjamin ^a   Popovic, Zoran B ^a   Wilkoff, Bruce L ^a   Desai, Milind Y ^a   Flamm, Scott D ^a   Marwick, Thomas ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL SCAR BURDEN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL TIME;

CORONARY ARTERY DISEASE;

AGED; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; CICATRIX; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEX FACTORS; STROKE VOLUME; SURVIVAL RATE;

EID: 84891833071     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-304261     Document Type: Article

References (36)

1. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
2. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
3. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. (Pubitemid 34984635)
4. Stecker EC, Vickers C, Waltz J, et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol 2006;47:1161-6.
5. Moss AJ, Greenberg H, Case RB, et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004;110:3760-5. (Pubitemid 40023973)
6. Reichlin T, Kuhne M, Sticherling C, et al. Characterization and financial impact of implantable cardioverter-defibrillator patients without interventions 5 years after implantation. QJM 2011;104:849-57.
7. Bello D, Fieno DS, Kim RJ, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005;45:1104-8. (Pubitemid 40432446)
8. Cheong BY, Muthupillai R, Wilson JM, et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 2009;120:2069-76.
9. Kwon DH, Halley CM, Carrigan TP, et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging 2009;2:34-44.
10. Kwon DH, Halley CM, Popovic ZB, et al. Gender differences in survival in patients with severe left ventricular dysfunction despite similar extent of myocardial scar measured on cardiac magnetic resonance. Eur J Heart Fail 2009;11:937-44.
11. Yan AT, Shayne AJ, Brown KA, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006;114:32-9. (Pubitemid 44305272)
12. Kwon DH, Hachamovitch R, Popovic ZB, et al. Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability. Circulation 2012;126 (11 Suppl 1):S3-8.
13. Gorgels AP, Gijsbers C, de Vreede-Swagemakers J, et al. Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 2003;24:1204-9.
14. Gao P, Yee R, Gula L, et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging 2012;5:448-56.
15. Klem I, Weinsaft JW, Bahnson TD, et al. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 2012;60:408-20.
16. Moss AJ, Schuger C, Beck CA, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012 367:2275-83.
17. Pacifico A, Hohnloser SH, Williams JH, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med 1999;340:1855-62. (Pubitemid 29272665)
18. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
19. Xie J, Weil MH, Sun S, et al. High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation 1997;96:683-8. (Pubitemid 27329451)
20. Haigney MC, Zareba W, Nasir JM, et al. Gender differences and risk of ventricular tachycardia or ventricular fibrillation. Heart Rhythm 2009;6:180-6.
21. Liu XK, Katchman A, Drici MD, et al. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther 1998;285:672-9. (Pubitemid 28237447)
22. Dash R, Frank KF, Carr AN, et al. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. J Mol Cell Cardiol 2001;33:1345-53. (Pubitemid 32613426)
23. Vizgirda VM, Wahler GM, Sondgeroth KL, et al. Mechanisms of sex differences in rat cardiac myocyte response to beta-adrenergic stimulation. Am J Physiol Heart Circ Physiol 2002;282:H256-63. (Pubitemid 34654157)
24. Nakagawa M, Ooie T, Ou B, et al. Gender differences in autonomic modulation of ventricular repolarization in humans. J Cardiovasc Electrophysiol 2005;16:278-84. (Pubitemid 40404592)
25. Wei SK, McCurley JM, Hanlon SU, et al. Gender differences in Na/Ca exchanger current and beta-adrenergic responsiveness in heart failure in pig myocytes. Ann N Y Acad Sci 2007;1099:183-9. (Pubitemid 47092592)
26. Hara M, Danilo P Jr, Rosen MR. Effects of gonadal steroids on ventricular repolarization and on the response to E4031. J Pharmacol Exp Ther 1998;285:1068-72. (Pubitemid 28277905)
27. Song M, Helguera G, Eghbali M, et al. Remodeling of Kv4.3 potassium channel gene expression under the control of sex hormones. J Biol Chem 2001;276:31883-90.
28. Ghanbari H, Dalloul G, Hasan R, et al. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med 2009;169:1500-6.
29. Russo AM, Poole JE, Mark DB, et al. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol 2008;19:720-4.
30. Russo AM, Stamato NJ, Lehmann MH, et al. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol 2004;15:993-8. (Pubitemid 39281526)
31. Santangeli P, Pelargonio G, Dello Russo A, et al. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm 2010;7:876-82.
32. Kannel WB, Wilson PW, D'Agostino RB, et al. Sudden coronary death in women. Am Heart J 1998;136:205-12. (Pubitemid 28368840)
33. Lampert R, McPherson CA, Clancy JF, et al. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol 2004;43:2293-9. (Pubitemid 38757601)
34. Yap YG, Duong T, Bland M, et al. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur Heart J 2005;26:1385-93. (Pubitemid 41373515)
35. Russo AM, Day JD, Stolen K, et al. Implantable cardioverter defibrillators: do women fare worse than men? Gender comparison in the INTRINSIC RV trial. J Cardiovasc Electrophysiol 2009;20:973-8.
36. Hachamovitch R, Nutter B, Cerqueira MD; AdreView Myocardial Imaging for Risk Evaluation in Heart Failure investigators. Predictors and frequency of ICD implantation for primary prevention in ICD eligible patients: results from a prospective multicenter registry. Circ Cardiovasc Qual Outcomes 2012;5:A107.